3.7 KiB
| type | title | author | url | date | domain | secondary_domains | format | status | priority | tags | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| source | Trump's Plan for AI: Recapping the White House's AI Action Plan | CSET Georgetown (@CSETGeorgetown) | https://cset.georgetown.edu/article/trumps-plan-for-ai-recapping-the-white-houses-ai-action-plan/ | 2025-07-23 | grand-strategy |
|
article | unprocessed | medium |
|
Content
CSET Georgetown's analysis of the White House "America's AI Action Plan" (July 23, 2025), authored by OSTP Director Michael Kratsios, AI/Crypto Advisor David Sacks, and NSA/Secretary of State Marco Rubio.
Key elements:
- AI-for-national-security as the primary frame: "winning the race" against China
- Biosecurity components: requires federally funded institutions to use nucleic acid synthesis providers with robust screening; directs OSTP to convene data-sharing mechanism for screening fraudulent/malicious customers
- Reinforces CAISI's role in evaluating frontier AI for national security risks including bio risks
- Explicitly acknowledges AI could create "new pathways for malicious actors to synthesize harmful pathogens"
The plan does NOT address DURC/PEPP institutional review committee replacement. It substitutes screening-based biosecurity governance for institutional oversight governance.
Agent Notes
Why this matters: The AI Action Plan reveals the OSTP's reorientation: biosecurity is addressed as a "screening" problem (which inputs are acceptable) rather than an "oversight" problem (which research gets conducted at all). This is a categorical substitution that leaves a governance vacuum for dual-use research at institutions. What surprised me: That Rubio is listed as a co-author in his capacity as NSA/Secretary of State — not a science role. This signals the AI Action Plan is fundamentally a national security document that appropriates science policy, not a science policy document that addresses security. The institutional authority for biosecurity governance has shifted from HHS/OSTP-as-science to NSA/State-as-security. What I expected but didn't find: Any provision addressing the 120-day DURC/PEPP replacement deadline from EO 14292. The AI Action Plan (July 2025) postdates the deadline (September 2025) and does not address the missed deadline. KB connections: anti-gain-of-function-framing-creates-structural-decoupling-between-ai-governance-and-biosecurity-governance-communities, durc-pepp-rescission-created-indefinite-biosecurity-governance-vacuum-through-missed-replacement-deadline Extraction hints: The "screening-based governance substituting for institutional oversight governance" distinction is a potential standalone claim. The institutional authority shift (HHS/OSTP-science to NSA/State-security) may also be extractable. Context: CSET Georgetown is the leading US academic center for emerging technology policy analysis. High quality secondary source.
Curator Notes (structured handoff for extractor)
PRIMARY CONNECTION: durc-pepp-rescission-created-indefinite-biosecurity-governance-vacuum-through-missed-replacement-deadline WHY ARCHIVED: The AI Action Plan's substitution of screening-based biosecurity governance for institutional oversight governance is the most concrete evidence of the "category substitution" finding — a weaker instrument replacing a stronger one while being framed as an improvement EXTRACTION HINT: The claim that "nucleic acid screening cannot perform the gate-keeping function of institutional review" is the key new argument. Extractor should look at RAND's biosecurity primer alongside this source for the full case.